These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19149503)

  • 1. Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections.
    Chaudhary M; Shrivastava SM; Sehgal R
    Curr Clin Pharmacol; 2009 Jan; 4(1):62-6. PubMed ID: 19149503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.
    Joshi M; Bernstein J; Solomkin J; Wester BA; Kuye O
    J Antimicrob Chemother; 1999 Mar; 43(3):389-97. PubMed ID: 10223595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effectiveness of ceftazidime and cefazolin/tobramycin in patients with inflammatory diseases of the lower respiratory tract].
    Vetter N; Feist H; Armbruster C; Drlicek M
    Infection; 1987; 15 Suppl 4():S192-4. PubMed ID: 3312033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
    Kljucar S; Heimesaat M; von Pritzbuer E; Olms K
    Infection; 1987; 15 Suppl 4():S185-91. PubMed ID: 3312032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
    Rodriguez JR; Ramirez-Ronda CH
    Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R; Overmeyer A; Knie B; Fleming PC; Levison H
    Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V; Roberts GW; Coulthard KP; Baghurst PA; Martin A; Roberts ME; Onishko CR; Martin AJ; Linke RJ; Holmes M; Jarvinen A; Kennedy D; Colebatch KA; Hansman D; Parsons DW
    Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
    Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
    Cone LA; Woodard DR; Stoltzman DS; Byrd RG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime vs. tobramycin for serious infections in urological patients.
    Tammela T; Kontturi M; Usenius R; Uusi-Penttilä S; Viitanen J; Jauhiainen K
    J Hosp Infect; 1990 Apr; 15 Suppl A():69-76. PubMed ID: 1971649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS; Cocchetto DM
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of ceftazidime in intractable respiratory tract infections].
    Takenaka S; Fukuda K; Kimura T; Shima K; Ushijima M; Egashira Y; Ikeda S; Hiraoka T; Higuchi S; Fujise T
    Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
    Madsen PO; Frimodt-Møller PC
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():77-9. PubMed ID: 6352658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.
    Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M
    J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.